Lupin gets approval to launch flu medicine in China, enters Chinese market for first time

Lupin has received approval in China for its flu treatment Oseltamivir oral suspension, marking the company’s first product launch in the Chinese market.

Leave a Reply

Your email address will not be published. Required fields are marked *